Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)

Part of paid clinical trials in Austin, Texas.

Sponsor
Natera, Inc.
Study ID
NCT07750886
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The SCORE-NHL study is a prospective, multi-center, study designed to collect data and biological samples from participants diagnosed with aggressive Stage I to IV non-Hodgkin Lymphoma (NHL). Study participants will undergo research blood collections of up to 60 mL as well as residual tissue collection, collected as part of a standard of care procedure, for use in research. Collected samples and data will be analyzed to evaluate biomarkers associated with development and validation of cancer monitoring and detection assays ("Natera cancer monitoring and detection test(s)").

Key Dates

First listed
Aug 6, 2026
Start date
Jul 27, 2026
Status verified
Jul 2026
Primary completion
Apr 30, 2032
Completion
Apr 30, 2032

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Primary Outcome - Blood and Residual Tissue Specimen Collection from 160 Completed Participants for Blood-Based Cancer Monitoring and Detection and Cancer Assay Development. [ Time Frame: 3 Years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Natera, Inc.AustinTexas78753
Radhakrishnan Ramchandren, MD
650-489-9050

Find similar trials in Austin, TX

By research site
Natera, Inc.· Austin, TX

Related Studies